Last reviewed · How we verify
Placebo (for Theophylline)
Placebo (for Theophylline) is a Small molecule drug developed by The George Institute. It is currently FDA-approved for Control arm in theophylline clinical trials. Also known as: Theophylline placebo 1 tab twice daily.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation rather than direct drug action.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation rather than direct drug action. Used for Control arm in theophylline clinical trials.
At a glance
| Generic name | Placebo (for Theophylline) |
|---|---|
| Also known as | Theophylline placebo 1 tab twice daily |
| Sponsor | The George Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to measure the effect of patient expectation and the natural disease course independent of active drug treatment. In this case, it serves as a control comparator in studies evaluating theophylline efficacy. Any observed benefit reflects placebo response, regression to the mean, or natural disease resolution rather than pharmacological activity.
Approved indications
- Control arm in theophylline clinical trials
Common side effects
Key clinical trials
- Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old (PHASE2)
- Theophylline Treatment for Pseudohypoparathyroidism (PHASE2)
- Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD (PHASE3)
- Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.
- Smell in Covid-19 and Efficacy of Nasal Theophylline (PHASE2)
- Preventing Acute Kidney Injury (AKI) in Pediatric Patients (PHASE3)
- Smell Changes & Efficacy of Nasal Theophylline (PHASE2)
- Theophylline for Depression Study (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Theophylline) CI brief — competitive landscape report
- Placebo (for Theophylline) updates RSS · CI watch RSS
- The George Institute portfolio CI
Frequently asked questions about Placebo (for Theophylline)
What is Placebo (for Theophylline)?
How does Placebo (for Theophylline) work?
What is Placebo (for Theophylline) used for?
Who makes Placebo (for Theophylline)?
Is Placebo (for Theophylline) also known as anything else?
What development phase is Placebo (for Theophylline) in?
Related
- Manufacturer: The George Institute — full pipeline
- Indication: Drugs for Control arm in theophylline clinical trials
- Also known as: Theophylline placebo 1 tab twice daily
- Compare: Placebo (for Theophylline) vs similar drugs
- Pricing: Placebo (for Theophylline) cost, discount & access